Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma

Michael A. Nalesnik, Randall G. Lee, Brian I. Carr

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We examined stage T1 to T4 hepatocellular carcinomas (HCC) to determine whether transforming growth factor alpha (TGFα) presence differed between early- and late-stage HCC and between tumors with low and high proliferative rates. Paraffin sections from 36 HCC were evaluated for TGFα and the proliferation markers Kiel 67 antigen (Ki67) or proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining. In 12 cases, double staining for TGFα and Ki67 was also performed. Eighty-one percent of tumors and 94% of adjacent liver sections contained TGFα. A trend toward inverse correlation was seen between the percentage of TGFα-positive tumor cells and the proliferative rate as determined by Ki67 staining. No clear correlation of TGFα to either tumor stage or percentage of PCNA-positive cells was seen. This study confirms the presence of TGFα in the majority of early- and late- stage HCC. Positivity within tumor tissue is consistent with autocrine or paracrine stimulation. A trend toward inverse correlation between TGFα- producing cells and the number of cycling cells suggests that rapidly proliferating tumors may consume this growth factor at an accelerated rate. Alternatively, other hepatic mitogens may have more functional significance in these latter tumors. Finally, the presence of TGFα in peritumoral hepatocytes suggests these cells as potential Sources of paracrine stimulation for HCC.

Original languageEnglish
Pages (from-to)228-234
Number of pages7
JournalHuman Pathology
Volume29
Issue number3
DOIs
Publication statusPublished - 1998

Fingerprint

Transforming Growth Factor alpha
Hepatocellular Carcinoma
Liver
Neoplasms
Proliferating Cell Nuclear Antigen
Staining and Labeling
Antigens
Mitogens
Paraffin
Hepatocytes
Intercellular Signaling Peptides and Proteins
Cell Count

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma. / Nalesnik, Michael A.; Lee, Randall G.; Carr, Brian I.

In: Human Pathology, Vol. 29, No. 3, 1998, p. 228-234.

Research output: Contribution to journalArticle

Nalesnik, Michael A. ; Lee, Randall G. ; Carr, Brian I. / Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma. In: Human Pathology. 1998 ; Vol. 29, No. 3. pp. 228-234.
@article{07df382dbf1545bf855c5193aa5d5710,
title = "Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma",
abstract = "We examined stage T1 to T4 hepatocellular carcinomas (HCC) to determine whether transforming growth factor alpha (TGFα) presence differed between early- and late-stage HCC and between tumors with low and high proliferative rates. Paraffin sections from 36 HCC were evaluated for TGFα and the proliferation markers Kiel 67 antigen (Ki67) or proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining. In 12 cases, double staining for TGFα and Ki67 was also performed. Eighty-one percent of tumors and 94{\%} of adjacent liver sections contained TGFα. A trend toward inverse correlation was seen between the percentage of TGFα-positive tumor cells and the proliferative rate as determined by Ki67 staining. No clear correlation of TGFα to either tumor stage or percentage of PCNA-positive cells was seen. This study confirms the presence of TGFα in the majority of early- and late- stage HCC. Positivity within tumor tissue is consistent with autocrine or paracrine stimulation. A trend toward inverse correlation between TGFα- producing cells and the number of cycling cells suggests that rapidly proliferating tumors may consume this growth factor at an accelerated rate. Alternatively, other hepatic mitogens may have more functional significance in these latter tumors. Finally, the presence of TGFα in peritumoral hepatocytes suggests these cells as potential Sources of paracrine stimulation for HCC.",
author = "Nalesnik, {Michael A.} and Lee, {Randall G.} and Carr, {Brian I.}",
year = "1998",
doi = "10.1016/S0046-8177(98)90040-5",
language = "English",
volume = "29",
pages = "228--234",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Transforming growth factor alpha (TGFα) in hepatocellular carcinomas and adjacent hepatic parenchyma

AU - Nalesnik, Michael A.

AU - Lee, Randall G.

AU - Carr, Brian I.

PY - 1998

Y1 - 1998

N2 - We examined stage T1 to T4 hepatocellular carcinomas (HCC) to determine whether transforming growth factor alpha (TGFα) presence differed between early- and late-stage HCC and between tumors with low and high proliferative rates. Paraffin sections from 36 HCC were evaluated for TGFα and the proliferation markers Kiel 67 antigen (Ki67) or proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining. In 12 cases, double staining for TGFα and Ki67 was also performed. Eighty-one percent of tumors and 94% of adjacent liver sections contained TGFα. A trend toward inverse correlation was seen between the percentage of TGFα-positive tumor cells and the proliferative rate as determined by Ki67 staining. No clear correlation of TGFα to either tumor stage or percentage of PCNA-positive cells was seen. This study confirms the presence of TGFα in the majority of early- and late- stage HCC. Positivity within tumor tissue is consistent with autocrine or paracrine stimulation. A trend toward inverse correlation between TGFα- producing cells and the number of cycling cells suggests that rapidly proliferating tumors may consume this growth factor at an accelerated rate. Alternatively, other hepatic mitogens may have more functional significance in these latter tumors. Finally, the presence of TGFα in peritumoral hepatocytes suggests these cells as potential Sources of paracrine stimulation for HCC.

AB - We examined stage T1 to T4 hepatocellular carcinomas (HCC) to determine whether transforming growth factor alpha (TGFα) presence differed between early- and late-stage HCC and between tumors with low and high proliferative rates. Paraffin sections from 36 HCC were evaluated for TGFα and the proliferation markers Kiel 67 antigen (Ki67) or proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining. In 12 cases, double staining for TGFα and Ki67 was also performed. Eighty-one percent of tumors and 94% of adjacent liver sections contained TGFα. A trend toward inverse correlation was seen between the percentage of TGFα-positive tumor cells and the proliferative rate as determined by Ki67 staining. No clear correlation of TGFα to either tumor stage or percentage of PCNA-positive cells was seen. This study confirms the presence of TGFα in the majority of early- and late- stage HCC. Positivity within tumor tissue is consistent with autocrine or paracrine stimulation. A trend toward inverse correlation between TGFα- producing cells and the number of cycling cells suggests that rapidly proliferating tumors may consume this growth factor at an accelerated rate. Alternatively, other hepatic mitogens may have more functional significance in these latter tumors. Finally, the presence of TGFα in peritumoral hepatocytes suggests these cells as potential Sources of paracrine stimulation for HCC.

UR - http://www.scopus.com/inward/record.url?scp=0031890981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031890981&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(98)90040-5

DO - 10.1016/S0046-8177(98)90040-5

M3 - Article

C2 - 9496824

AN - SCOPUS:0031890981

VL - 29

SP - 228

EP - 234

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -